George Vande Woude
Affiliations: | National Cancer Institute, Rockville, MD, United States |
Google:
"George Woude"Collaborators
Sign in to add collaborator| Donald P Bottaro | collaborator | 1990-2012 | National Cancer Institute - Frederick (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Paulson A, Linklater E, Berghuis B, et al. (2013) Abstract 3022: MET and ERBB2 are coexpressed in ERBB2+ breast cancers and contribute to innate resistance. Cancer Research. 73: 3022-3022 |
| Anderson TR, Hubbard G, Daniel AR, et al. (2013) Abstract 2927: Breast tumor kinase (Brk/PTK6) mediates hypoxia/HIF-1α-associated breast cancer progression. Cancer Research. 73: 2927-2927 |
| Gherardi E, Birchmeier W, Birchmeier C, et al. (2012) Targeting MET in cancer: rationale and progress Nature Reviews Cancer. 12: 89-103 |
| Graveel CR, Paulson A, Linklater E, et al. (2012) Abstract 4864: Targeting MET and ERBB2 signaling in aggressive breast cancers Cancer Research. 72: 4864-4864 |
| Gao C, Su Y, Woude GV. (2012) Abstract 326: Aneuploidy-driven clonal diversification underlies tumor phenotype switching Cancer Research. 72: 326-326 |
| Gherardi E, Birchmeier W, Birchmeier C, et al. (2012) Erratum: Targeting MET in cancer: rationale and progress Nature Reviews Cancer. 12: 637-637 |
| Kentsis A, Sanda T, Ngo V, et al. (2010) Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia. Blood. 116: 1042-1042 |
| Zhang Y, Staal B, Essenburg C, et al. (2010) Abstract LB-305: Why two are better than one: Suppression of carcinoma cell growthin vitroand in human HGF/SF transgenic SCID by inhibitors of MET (SGX523) and EGFR (erlotinib) Cancer Research. 70 |
| Knudsen BS, Woude GV. (2008) Showering c-MET-dependent cancers with drugs. Current Opinion in Genetics & Development. 18: 87-96 |
| Graveel C, Su Y, Koeman J, et al. (2004) Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele Proceedings of the National Academy of Sciences of the United States of America. 101: 17198-17203 |